Citation Impact
Citing Papers
CTLA-4 Control over Foxp3 + Regulatory T Cell Function
2008 StandoutScienceNobel
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy
2015 StandoutScience
Novel Tryptophan Catabolic Enzyme IDO2 Is the Preferred Biochemical Target of the Antitumor Indoleamine 2,3-Dioxygenase Inhibitory Compound d -1-Methyl-Tryptophan
2007
Construction of self-recognizing regulatory T cells from conventional T cells by controlling CTLA-4 and IL-2 expression
2013 StandoutNobel
CD4+ Tregs and immune control
2004 StandoutNobel
Constitutive Expression of IDO by Dendritic Cells of Mesenteric Lymph Nodes: Functional Involvement of the CTLA-4/B7 and CCL22/CCR4 Interactions
2009 StandoutNobel
Epidemiology and causes of preterm birth
2008 Standout
The role of CD28 and cytotoxic T‐lymphocyte antigen‐4 (CTLA‐4) in regulatory T‐cell biology
2006
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment
2013
Ido expression by dendritic cells: tolerance and tryptophan catabolism
2004 Standout
Complement Receptors CD21/35 Link Innate and Protective Immunity during Streptococcus pneumoniae Infection by Regulating IgG3 Antibody Responses
2002
Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8+ T cells directly within the tumor microenvironment
2014
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
2011 StandoutNature
Fundamental Cellular Processes Do Not Require Vertebrate-specific Sequences within the TATA-binding Protein
2003 StandoutNobel
T cell apoptosis by tryptophan catabolism
2002
Host Indoleamine 2,3-Dioxygenase: Contribution to Systemic Acquired Tumor Tolerance
2012
Consensual immunity: success-driven development of T-helper-1 and T-helper-2 responses
2005
Regulatory T cells mediate maternal tolerance to the fetus
2004 Standout
Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis
2015 Standout
Human nutrition, the gut microbiome and the immune system
2011 StandoutNature
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Macrophage-specific PPARγ controls alternative activation and improves insulin resistance
2007 StandoutNature
Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self
2005 StandoutNobel
Evolving concepts of rheumatoid arthritis
2003 StandoutNature
Functional expression of indoleamine 2,3-dioxygenase by murine CD8α+ dendritic cells
2002
Rhythmic Expression of MicroRNA-26a Regulates the L-type Voltage-gated Calcium Channel α1C Subunit in Chicken Cone Photoreceptors
2009
Systemic Lupus Erythematosus
2011 Standout
The preterm parturition syndrome
2006 Standout
Autoimmunity, Complement Activation, Tissue Injury and Reciprocal Effects
2003
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
2015 Standout
The Classical Complement Cascade Mediates CNS Synapse Elimination
2007 Standout
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
2004 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Complement: more than a ‘guard’ against invading pathogens?
2002
Cancer immunotherapy comes of age
2011 StandoutNature
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
Origin and physiological roles of inflammation
2008 StandoutNature
Heparin prevents antiphospholipid antibody–induced fetal loss by inhibiting complement activation
2004
Creating immune privilege: active local suppression that benefits friends, but protects foes
2007
CTLA-4–Ig regulates tryptophan catabolism in vivo
2002
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
2015 StandoutNature
The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells
2008 StandoutNobel
Points of control in inflammation
2002 StandoutNature
Indoleamine 2,3-dioxygenase and tumor-induced tolerance
2007
Removing the Vertebrate-Specific TBP N Terminus Disrupts Placental β2m-Dependent Interactions with the Maternal Immune System
2002 StandoutNobel
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
2011 StandoutNobel
Regulation of immune responses by L-arginine metabolism
2005
Gene Signature in Melanoma Associated With Clinical Activity
2010
Alternative activation of macrophages
2003 Standout
Mechanisms of effects of complement inhibition in murine collagen‐induced arthritis
2002
Scurfin (FOXP3) Acts as a Repressor of Transcription and Regulates T Cell Activation
2001 StandoutNobel
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
2006 StandoutScience
CD4+CD25−LAG3+regulatory T cells controlled by the transcription factor Egr-2
2009 StandoutNobel
Systems analysis identifies an essential role for SHANK-associated RH domain-interacting protein (SHARPIN) in macrophage Toll-like receptor 2 (TLR2) responses
2011 StandoutNobel
The C-type lectin SIGN-R1 mediates uptake of the capsular polysaccharide ofStreptococcus pneumoniaein the marginal zone of mouse spleen
2003 StandoutNobel
A critical role for the programmed death ligand 1 in fetomaternal tolerance
2005
Suppression of T cell function: a potential role for transcriptional repressor ICER
2000
Decreased osteoclastogenesis in serotonin-deficient mice
2012
Blockade of B7-H1 on Macrophages Suppresses CD4+ T Cell Proliferation by Augmenting IFN-γ-Induced Nitric Oxide Production
2005
Cells Expressing Indoleamine 2,3-Dioxygenase Inhibit T Cell Responses
2002
The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors
2008 StandoutNobel
The Role of Complement in the Development of Systemic Lupus Erythematosus
2004
Induction of autoimmune disease by deletion of CTLA-4 in mice in adulthood
2016 StandoutNobel
CD4+ Tregs and immune control
2004 StandoutNobel
Germinal Centers
2012
Ligation of B7-1/B7-2 by Human CD4+ T Cells Triggers Indoleamine 2,3-Dioxygenase Activity in Dendritic Cells
2004
PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells
2003 StandoutNobel
Tryptophan-derived Catabolites Are Responsible for Inhibition of T and Natural Killer Cell Proliferation Induced by Indoleamine 2,3-Dioxygenase
2002
Unique potential of 4-1BB agonist antibody to promote durable regression of HPV + tumors when combined with an E6/E7 peptide vaccine
2015 StandoutNobel
Indoleamine 2,3-Dioxygenase Serves as a Marker of Poor Prognosis in Gene Expression Profiles of Serous Ovarian Cancer Cells
2005
Preterm labor: One syndrome, many causes
2014 StandoutScience
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
2010 StandoutNobel
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
2005 Standout
Tolerogenic Dendritic Cells
2003 StandoutNobel
Nascent-Seq analysis of Drosophila cycling gene expression
2013 StandoutNobel
Structural basis for Zika envelope domain III recognition by a germline version of a recurrent neutralizing antibody
2020 StandoutNobel
Enhancement of Antibodies to the Human Immunodeficiency Virus Type 1 Envelope by Using the Molecular Adjuvant C3d
2003
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
2013 StandoutNobel
Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity
2017 StandoutNobel
Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells
2002
Works of Dailing Mao being referenced
PLCγ2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2
2006
Differential Regulation and Transcriptional Control of Immediate Early Gene Expression in Forskolin-Treated WEHI7.2 Thymoma Cells
1998
A Critical Role for Murine Complement Regulator Crry in Fetomaternal Tolerance
2000 Science
A Role for the Cr2 Gene in Modifying Autoantibody Production in Systemic Lupus Erythematosus
2002
Impaired Affinity Maturation inCr2−/− Mice Is Rescued by Adjuvants Without Improvement in Germinal Center Development
2000
Prevention of T cell–driven complement activation and inflammation by tryptophan catabolism during pregnancy
2001
Complement C3 Activation Is Required for Antiphospholipid Antibody-induced Fetal Loss
2002